NCT00932074 - A Study to Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions

Atopic Dermatitis

Interventions

DRUG

KP-413 Ointment

Study drug ointment to be applied topically to the selected treatment areas on the head/neck and torso/limbs twice a day for 4 weeks.

Trial Locations (6)

Michigan Center for Research Corp, Clinton Twp.

Dermatology Treatment & Research Center, PA, Dallas

J & S Studies, Inc., College Station

DermResearch, Inc., Austin

Oregon Medical Research Center, PC, Portland

The Education & Research Foundation, Inc, Lynchburg